# Non-invasive Carbon Dioxide Monitoring and Endoscopic Retrograde Cholangiopancreatography Patients

> **NCT04481308** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 150 (estimated)

## Conditions studied

- Patient Monitoring

## Interventions

- **DRUG:** propofol (2 mg/kg) and fentanyl (1ug/kg) and 4 liters O2 flow through nasal cannula

## Key facts

- **NCT ID:** NCT04481308
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481308, "Non-invasive Carbon Dioxide Monitoring and Endoscopic Retrograde Cholangiopancreatography Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04481308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*